Sangamo Therapeutics, Inc. (SGMOQ)
0.161
-0.01
(-3.13%)
USD |
OTCM |
Sep 04, 16:00
Sangamo Therapeutics SG&A Expense (TTM) : 31.64M for March 31, 2026
SG&A Expense (TTM) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical SG&A Expense (TTM) Data
| Date | Value |
|---|---|
| March 31, 2026 | 31.64M |
| December 31, 2025 | 34.89M |
| September 30, 2025 | 36.99M |
| June 30, 2025 | 40.05M |
| March 31, 2025 | 43.02M |
| December 31, 2024 | 44.73M |
| September 30, 2024 | 47.96M |
| June 30, 2024 | 50.83M |
| March 31, 2024 | 54.80M |
| December 31, 2023 | 61.17M |
| September 30, 2023 | 130.69M |
| June 30, 2023 | 133.01M |
| March 31, 2023 | 132.09M |
| December 31, 2022 | 128.86M |
| September 30, 2022 | 114.12M |
| June 30, 2022 | 112.39M |
| March 31, 2022 | 113.78M |
| December 31, 2021 | 115.02M |
| September 30, 2021 | 64.01M |
| June 30, 2021 | 65.68M |
| March 31, 2021 | 67.13M |
| December 31, 2020 | 67.10M |
| September 30, 2020 | 103.60M |
| June 30, 2020 | 102.35M |
| March 31, 2020 | 99.02M |
| Date | Value |
|---|---|
| December 31, 2019 | 100.02M |
| September 30, 2019 | 60.99M |
| June 30, 2019 | 57.06M |
| March 31, 2019 | 53.77M |
| December 31, 2018 | 46.74M |
| September 30, 2018 | 39.85M |
| June 30, 2018 | 35.28M |
| March 31, 2018 | 30.01M |
| December 31, 2017 | 27.20M |
| September 30, 2017 | 24.60M |
| June 30, 2017 | 23.20M |
| March 31, 2017 | 28.25M |
| December 31, 2016 | 26.33M |
| September 30, 2016 | 26.36M |
| June 30, 2016 | 25.90M |
| March 31, 2016 | 19.82M |
| December 31, 2015 | 19.20M |
| September 30, 2015 | 18.64M |
| June 30, 2015 | 17.81M |
| March 31, 2015 | 16.76M |
| December 31, 2014 | 15.68M |
| September 30, 2014 | 15.55M |
| June 30, 2014 | 14.98M |
| March 31, 2014 | 14.14M |
| December 31, 2013 | 13.80M |
SG&A Expense (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
SG&A Expense (TTM) Benchmarks
| Arrowhead Pharmaceuticals, Inc. | 172.57M |
| Oncolytics Biotech, Inc. | 16.62M |
| Sarepta Therapeutics, Inc. | 436.74M |
| Anixa Biosciences, Inc. | 6.118M |
| Vicapsys Life Sciences, Inc. | -0.0004M |